Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Jin Han

Jin Han


Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Clinical Associate Professor, University of Illinois at Chicago

Contact

Address:

833 S. Wood Street Rm 164 (MC886), Chicago, IL

Office Phone:

(312) 355-1213 (work)

Related Sites:

About Heading link

Research Interests:
Pain management, sickle cell disease (SCD), safety and effectiveness of agents used in SCD, evaluation of clinical pharmacy services and interventions, and pharmacogenomics.

Teaching and Supervision Heading link

PDAT 9: Hematology/Oncology (PHAR 509), 1/1/2022 – 4/30/2022
PDAT 9: Hematology/Oncology (PHAR 509), 1/1/2022 – 4/30/2022
Pharmacokinetics (PHAR 435), 8/29/2021 – 12/31/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
PDAT 9: Hematology/Oncology (PHAR 509), 1/11/2021 – 4/30/2021
PDAT 9: Hematology/Oncology (PHAR 509), 1/11/2021 – 4/30/2021

Selected Grants

Sickle Treatment and Outcomes Research in the Midwest (STORM), Cincinnati Childrens Hospital Medical Center., 9/1/2021 - 8/31/2022, Obligated Amount: $55000; Anticipated Amount: $55000

Platelet Decline as a Predictor of Complications in Sickle Cell Disease Sickle cell disease, Takeda Pharmaceuticals., 3/3/2021 - 8/31/2022, Obligated Amount: $216729.81; Anticipated Amount: $216729.81

The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias, ApoPharma., 12/12/2014 - 10/1/2015, No Obligated Amount Set; No Anticipated Amount Set

Protein Phosphatases in Lymphocyte Signal Transduction, National Institutes of Health., 7/1/2005 - 3/31/2010, No Obligated Amount Set; No Anticipated Amount Set

Development of CD1d-restricted NKT cells, National Institutes of Health., 3/15/1996 - 6/30/2012, No Obligated Amount Set; No Anticipated Amount Set

Selected Publications

Han, Jin, Molokie, Robert E, Hussain, Faiz, Njoku, Franklin, Gordeuk, Victor R, Saraf, Santosh L. (2022). Voxelotor and albuminuria in adults with sickle cell anaemia. British Journal of Haematology. doi:10.1111/bjh.18076.

Zolekar, Ashwini, Kim, Kibum, Lee, James C, Han, Jin, Duarte, Julio D, Galanter, William L, Cavallari, Larisa H, Nutescu, Edith A. (2022). Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing. Pharmacogenomics, 23, (2), 85-95. doi:10.2217/pgs-2021-0109.

Elmasri, Annesti F, Hur, Heejin, Han, Jin, Lee, James C. (2021). Genotype-Guided vs Clinically-Guided Stable Warfarin Dose Prediction and Stable Dose Establishment In A Predominantly Non-European Ancestry Population. Expert Review of Precision Medicine and Drug Development, 6, (6), 375-379. doi:10.1080/23808993.2021.1989303.

Njoku, Franklin, Zhang, Xu, Shah, Binal N, Machado, Roberto F, Han, Jin, Saraf, Santosh L, Gordeuk, Victor R. (2021). Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study. British Journal of Haematology, 194, (4), 767-778. doi:10.1111/bjh.17682.

Han, Jin, Srisuwananukorn, Andrew, Shah, Binal N, Molokie, Robert E, Lash, James P, Gordeuk, Victor R, Saraf, Santosh L. (2021). Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease. eJHaem, 2, (3), 483-484. doi:10.1002/jha2.259.

Zhou, Jifang, Sweiss, Karen, Han, Jin, Ko, Naomi Y, Patel, Pritesh R, Chiu, Brian C-H, Calip, Gregory S. (2021). Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Network Open, 4, (7), e2118410. doi:10.1001/jamanetworkopen.2021.18410.

Han, Jin, Saraf, Santosh L, Gowhari, Michel, Hussain, Faiz Ahmed, Jain, Shivi, Kavoliunaite, Laura, Molokie, Robert E, Gordeuk, Victor R. (2021). Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease. Annals of Pharmacotherapy, 56, (2), 222-223. doi:10.1177/10600280211024524.

Rahman, Syeda, Srisuwananukorn, Andrew, Molokie, Robert E, Gowhari, Michel, Njoku, Franklin, Hussain, Faiz Ahmed, Lee, James, Nutescu, Edith A, Gordeuk, Victor R, Saraf, Santosh L, Han, Jin. (2021). Evaluation of point‐of‐care International Normalized Ratio in sickle cell disease. Research and Practice in Thrombosis and Haemostasis, 5, (4), e12533. doi:10.1002/rth2.12533.

Zhou, Jifang, Sweiss, Karen, Nutescu, Edith A, Han, Jin, Patel, Pritesh R, Ko, Naomi Y, Lee, Todd A, Chiu, Brian C-H, Calip, Gregory S. (2021). Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare.. JCO Oncology Practice, 17, (3), e294-e312. doi:10.1200/op.20.00479.

Professional Leadership

ACCP 2023 Annual Meeting Program Committee, 10/15/2021 - Present

Education

Degrees:
PharmD, University of Illinois at Chicago, United States
PhD, Baylor College of Medicine, Texas
BS, Peking University, China

Postgraduate Training:
PGY1 Pharmacy Resident, Rush University Medical Center, United States
Howard Hughes Medical Institute Postdoctoral Fellow, University of Chicago, United States

Licensures and Certifications

Registered Pharmacist, State of Illinois, Date Not Set - Present
Pharmacotherapy Specialist, Board of Pharmacy Specialties, Date Not Set - Present

Selected Presentations

Han, Jin, Kevin, Wake, Emily, Tsiao. (2022 March 30). A Managed Care Approach to Racial Health Disparities in Sickle Cell Disease. AMCP Annual Meeting. Chicago, US.
Han, Jin. (2021 October 22). Medication accessibility in managing a rare disease, sickle cell anemia. The Forbidden City International Pharmacist Forum. Virtual.